Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-010111

Adverum Biotechnologies, Inc. · ADVM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Mehdi Gasmi
Officer — Chief Science & Tech Officer
Period of report
Feb 9, 2017
Accepted (ET)
Feb 13, 2017 · 5:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501756

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Feb 9, 2017A125,000$0.00A289,535D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F3$2.70Feb 9, 2017A181,000A—Feb 8, 2027Common Stock181,000181,000D

Explanation of responses